Moffitt Cancer Center's research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances. As pioneers of immunotherapy as a groundbreaking cancer treatment, we are excited to participate in the Society for Immunotherapy of Cancer Annual Meeting from November 1-5. The studies our scientists present explore many advances in areas like radiomics, checkpoint inhibitors and TIL therapy covering many cancer types. Be sure to visit our Booth #428 to meet members of the team and learn more about the impact Moffitt is making in cancer research, outcomes and advancements.
To learn more about Moffitt’s research and breakthroughs, follow Moffitt on LinkedIn and Twitter (@MoffittNews) or subscribe to one of our newsletters.
2023 Featured Articles
New Approach Using mRNA Generates Cellular Immunotherapy Within the Body
In vivo CAR macrophage therapy can be used to treat solid tumors
Immunotherapy Clinical Trial Tackles Barriers to Treating Uveal Melanoma Liver Metastasis
Therapy uses a pressure enabled delivery system to deliver immunotherapy to the tumor
Moffitt Study Aims to Improve Personalized Cancer Vaccines
Selection of neoantigen target critical to therapy’s success
Press Contact